Target intelligence / Profile preview

Corneal stromal collagen fiber

Molecular classification
Other (Extracellular matrix structural protein; not a classical drug target such as receptor, enzyme, transporter, or channel)
01

Overview

Corneal stromal collagen fibers are highly organized structural proteins predominantly composed of type I collagen, with additional contributions from types V, VI, XII, XIII, XIV, and XXIV collagen[1][5]. These fibers are assembled into narrow, uniform-diameter fibrils (∼30–31 nm), which are precisely arranged in parallel, superimposed lamellae throughout the corneal stroma[2][5]. The ordered architecture, aided by proteoglycans that maintain inter-fibrillar spacing, is essential for corneal transparency and refractive function[1][4]. Collagen fibers provide the main mechanical strength of the cornea and their organization is critical for both shape and optical properties. Disruption or alteration of the normal collagen fiber structure leads to loss of transparency and corneal diseases such as keratoconus, dystrophies, or opacity[6]. While not considered a drug target in the traditional sense (i.e., not a receptor, enzyme, or transporter), corneal stromal collagen fibers are a focus for research on tissue engineering, regenerative medicine, and interventions such as corneal cross-linking.

Other names
Corneal collagen fiberCollagen fibril of corneal stromaCorneal collagen fibril
02

Biological functions

Maintenance of corneal transparencyDetermination of corneal shape and mechanical strengthStructural support within corneal stromaRegulation of light transmission through the corneaMediation of corneal wound healing and biomechanics
03

Disease associations

Corneal dystrophies (e.g., cornea plana linked to mutations in collagen or proteoglycan-related genes)Corneal opacification (changes in collagen organization)Keratoconus (altered collagen structure and arrangement)Corneal ectasia
04

Safety considerations

Challenges in surgical manipulation (e.g., risk of scarring or haze due to collagen disruption)Poor regenerative capacity and risk of non-transparent scar formation following injury or surgery
05

Biomarkers

Mutations in collagen-related genes (e.g., keratocan, lumican) can serve as genetic biomarkers for corneal structural disordersDisorganization of collagen fibers detectable by imaging (OCT, confocal microscopy) is a biomarker for corneal diseases

Beyond the preview

Go deeper on Corneal stromal collagen fiber.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal stromal collagen fiber.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call